Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its third quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Tuesday, November 9, 2021.
Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details:
Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international)
Conference ID: 8198297
Webcast: Available in the “Investors” section of the Ocugen website and archived for approximately 45 days following the call
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.